- In June 2024, the American Society of Plastic Surgeons (ASPS) reported a 7.8% year-over-year increase in male breast reduction surgeries in the U.S., reflecting a growing social acceptance of cosmetic procedures among men and increased awareness of gynecomastia treatmentsThis surge highlights a shifting trend in male aesthetics and supports continued market growth
- In May 2024, Cutera, Inc., a leading provider of energy-based aesthetic systems, launched an upgraded liposuction-assisted RF platform, which is gaining popularity among cosmetic surgeons performing gynecomastia procedures. The new platform allows greater precision and reduced downtime, enhancing patient outcomes and supporting the company’s position in the male body contouring market
- In March 2024, GALDERMA announced the expansion of its aesthetic education programs to include male-focused treatment protocols, including gynecomastia and other male body procedures. This initiative is designed to empower practitioners with targeted knowledge and enhance treatment outcomes for male patients
- In February 2024, AbbVie Inc. announced strategic investment in R&D for male-specific aesthetic solutions, including innovations in fat reduction and tissue tightening, aimed at strengthening its portfolio in male-focused procedures such as gynecomastia. This reflects the company’s long-term strategy to expand in the men's aesthetics segment
- In January 2024, Merz Aesthetics partnered with leading plastic surgeons across Europe and North America to publish clinical guidelines for gynecomastia treatments. The guidelines offer standardized protocols for liposuction and excision techniques, helping improve procedure consistency and safety, and reinforcing Merz’s thought leadership in aesthetic medicine
